BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36440692)

  • 41. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
    Omichi K; Shindoh J; Cloyd JM; Mizuno T; Chun YS; Conrad C; Aloia TA; Tzeng CD; Vauthey JN
    Eur J Surg Oncol; 2018 Jan; 44(1):122-129. PubMed ID: 29208318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histopathological prognostic factors for colorectal liver metastases: A systematic review and meta-analysis of observational studies.
    de Oliveira CVC; Fonseca GM; Kruger JAP; de Mello ES; Coelho FF; Herman P
    Histol Histopathol; 2021 Feb; 36(2):159-181. PubMed ID: 33165892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database.
    Hallet J; Cunha AS; Adam R; Goéré D; Azoulay D; Mabrut JY; Muscari F; Laurent C; Navarro F; Pessaux P;
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):894-903. PubMed ID: 27573524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases.
    Nishioka Y; Chun YS; Overman MJ; Cao HST; Tzeng CD; Mason MC; Kopetz SW; Bauer TW; Vauthey JN; Newhook TE;
    J Am Coll Surg; 2022 Apr; 234(4):474-483. PubMed ID: 35290266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined colon and hepatic resection for synchronous colorectal liver metastases.
    Lyass S; Zamir G; Matot I; Goitein D; Eid A; Jurim O
    J Surg Oncol; 2001 Sep; 78(1):17-21. PubMed ID: 11519063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Liver resection in patients with metastases of colorectal cancers. Results and prognostic factors].
    Hohenberger P; Schlag P; Schwarz V; Herfarth C
    Chirurg; 1988 Jun; 59(6):410-7. PubMed ID: 3203563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Retrospective investigation of patients receiving additional surgery after endoscopic non-curative resection for early colorectal cancer].
    Sun YM; Zhang DS; Feng YF; Wang Y; Xu ZW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):486-491. PubMed ID: 32842429
    [No Abstract]   [Full Text] [Related]  

  • 51. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
    de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
    Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resection of pulmonary metastases from colon and rectal cancer: factors to predict survival differ regarding to the origin of the primary tumor.
    Meimarakis G; Spelsberg F; Angele M; Preissler G; Fertmann J; Crispin A; Reu S; Kalaitzis N; Stemmler M; Giessen C; Heinemann V; Stintzing S; Hatz R; Winter H
    Ann Surg Oncol; 2014 Aug; 21(8):2563-72. PubMed ID: 24668147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
    Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
    Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
    [No Abstract]   [Full Text] [Related]  

  • 55. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.
    Yamada H; Kondo S; Okushiba S; Morikawa T; Katoh H
    World J Surg; 2001 Sep; 25(9):1129-33. PubMed ID: 11571947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM
    Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Introduction of the resection severity index as independent risk factor limiting survival after resection of colorectal liver metastases.
    Gwiasda J; Schrem H; Kaltenborn A; Mahlmann J; Mix H; Lehner F; Kayser N; Klempnauer J; Kulik U
    Surg Oncol; 2017 Dec; 26(4):382-388. PubMed ID: 29113656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrence and survival after curative-intent treatment for colorectal liver metastases: Implications for adjuvant liver-directed regional chemotherapy.
    Kolbeinsson HM; Hoppe A; Walker J; Chandana S; Assifi MM; Chung M; Wright GP
    J Surg Oncol; 2022 Mar; 125(4):664-670. PubMed ID: 34796521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases after hepatic resection: which method to use?
    Dede K; Salamon F; Landherr L; Jakab F; Bursics A
    Pathol Oncol Res; 2015 Jan; 21(1):173-9. PubMed ID: 24898285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases.
    Zorzi D; Mullen JT; Abdalla EK; Pawlik TM; Andres A; Muratore A; Curley SA; Mentha G; Capussotti L; Vauthey JN
    J Gastrointest Surg; 2006 Jan; 10(1):86-94. PubMed ID: 16368496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.